Teva Pharmaceutical Industries Ltd. (TEVA)
30.18
+0.38
(+1.28%)
USD |
NYSE |
Dec 11, 16:00
30.19
+0.01
(+0.03%)
After-Hours: 20:00
Teva Pharmaceutical Industries Profit Margin (Quarterly): 9.71% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Novo Nordisk A/S | 26.68% |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -- |
| Nasus Pharma Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 10.27% |
| Return on Assets | 1.67% |
| Return on Invested Capital | 2.75% |
| Gross Profit Margin (Quarterly) | 51.33% |
| Operating Margin (Quarterly) | 23.84% |
| Return on Net Operating Assets | 2.00% |